Search

Search Constraints

You searched for: Author/Creator Switchenko, Jeffrey M.

Search Results

1. A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non‐Hodgkin's lymphoma. (7th August 2015)

2. Role of adjuvant therapy in resected stage IA subcentimeter (T1a/T1b) pancreatic cancer. Issue 1 (20th November 2018)

4. Survival outcomes by high‐risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity‐scored analysis of the National Cancer Data Base. Issue 16 (23rd April 2019)

6. Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia. Issue 4 (3rd April 2018)

7. Prognostic value of radiographically defined extranodal extension in human papillomavirus‐associated locally advanced oropharyngeal carcinoma. Issue 9 (2nd May 2019)

8. Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx. Issue 5 (11th December 2018)

9. Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma. Issue 12 (2nd December 2018)